
浏览全部资源
扫码关注微信
江苏省中医院,南京中医药大学 附属医院,南京 210029
蔡平,在读博士,主治中医师,从事脊柱外科微创手术和中西医结合快速康复研究,E-mail:njspine@163.com
* 杨挺,博士,副主任中医师,副教授,从事退变性脊柱病的中西医结合临床和基础研究,E-mail:dryangting2009@163.com
收稿日期:2020-09-08,
网络出版日期:2020-09-24,
纸质出版日期:2020-12-20
移动端阅览
蔡平,陈刚,夏建龙等.独活寄生汤联合盘黄间隙微创减压治疗肾气亏虚型退变性腰椎管狭窄症的中长期临床观察[J].中国实验方剂学杂志,2020,26(24):103-107.
CAI Ping,CHEN Gang,XIA Jian-long,et al.Middle and Long-term Clinical Effiacacy of Duhuo Jishengtang Combined with Minimally Invasive Decompression of Lumber Spine in Treatment of Degenerative Lumbar Spinal Stenosis with Kidney Deficiency Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(24):103-107.
蔡平,陈刚,夏建龙等.独活寄生汤联合盘黄间隙微创减压治疗肾气亏虚型退变性腰椎管狭窄症的中长期临床观察[J].中国实验方剂学杂志,2020,26(24):103-107. DOI: 10.13422/j.cnki.syfjx.20202424.
CAI Ping,CHEN Gang,XIA Jian-long,et al.Middle and Long-term Clinical Effiacacy of Duhuo Jishengtang Combined with Minimally Invasive Decompression of Lumber Spine in Treatment of Degenerative Lumbar Spinal Stenosis with Kidney Deficiency Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(24):103-107. DOI: 10.13422/j.cnki.syfjx.20202424.
目的
2
随访观察独活寄生汤联合盘黄间隙微创减压治疗肾气亏虚型退变性腰椎管狭窄症的3年以上临床疗效。
方法
2
通过单中心、平行随机对照临床试验设计,对2015年10月至2017年4月在江苏省中医院住院接受局麻盘黄间隙微创减压治疗的63例肾气亏虚型退变性腰椎管狭窄症患者行3年以上临床疗效观察。其中手术联合中药组(观察组)31例,手术联合塞来昔布、甲钴胺组(对照组)32例。两组术后均予一般治疗,观察组术后加用3周独活寄生汤口服,对照组术后加用塞来昔布、甲钴胺口服3周。
结果
2
在疼痛改善方面,仅术后3月随访时观察组优于对照组(
P
<
0.05),其他随访节点未见优势。术后3个月以及更长时间的随访,证实观察组在腰椎神经功能改善方面具有显著优势(
P
<
0.01)。末次随访时,观察组疗效优良率为83.87%(26/31),对照组疗效优良率62.5%(20/32),差异无统计学意义。两组患者末次随访时均无不稳定表现,组内前后比较和组间比较,差异均无统计学意义。
结论
2
术后3年有效随访证实局麻盘黄间隙微创减压治疗腰椎管狭窄症中长期随访效果满意,手术对腰椎节段稳定性无影响。口服独活寄生汤能够促进肾气亏虚型退变性腰椎管狭窄症患者术后神经功能恢复,提高临床治疗优良率,但在疼痛症状改善方面未见明显优势。
Objective
2
To observe the clinical efficacy of Duhuo Jishengtang combined with minimally invasive decompression of lumber spine in the treatment of degenerative lumbar spinal stenosis with kidney deficiency syndrome for more than 3 years.
Method
2
Through a single-center parallel randomized controlled clinical trial, 63 patients with degenerative lumbar spinal stenosis who were hospitalized in Jiangsu Hospital of Traditional Chinese Medicine from October 2015 to April 2017 were observed for more than three years. Among them, there were 31 cases in the operation combined with traditional Chinese medicine group (observation group) and 32 cases in the operation combined with Celebrex and Mecobalamin group (control group). Both groups were given routine treatment. The observation group was treated with Duhuo Jishengtang for 3 weeks, while the control group was treated with Celebrex and Mecobalamin for 3 weeks.
Result
2
In the aspect of pain improvement, only 3 months after operation, the observation group was superior to the control group (
P
<
0.05), with no significant advantage at other time nodes during follow-up. During the 3-month follow-up and a longer period, it was confirmed that observation group had a significant advantage in improving lumbar function (
P
<
0.01). At the last follow-up, the good efficacy rate of observation group was 83.87% (26/31), while the good efficacy rate of the control group was 62.5% (20/32). There was no unstable performance in the last follow-up of the two groups. There was no statistically significant difference between two groups.
Conclusion
2
The middle and long-term follow-up for minimally invasive decompression of lumber spine showed a satisfactory efficacy in the treatment of degenerative lumbar spinal stenosis, with no impact on the stability of the operative segments. For patients of lumbar spinal stenosis with kidney deficiency syndrome, Duhuo Jishengtang can promote the recovery of postoperative neurological function, and improve the good efficacy rate of clinical treatment, but with no obvious advantage in pain relieve after operation.
陆兵 . 保守及手术治疗对腰椎管狭窄患者预后及治疗成本的影响 [J]. 医药论坛杂志 , 2018 , 39 ( 2 ): 97 - 99 .
冯殿发 , 崔采云 . 腰椎管狭窄症经保守治疗后远期症状恶化的相关因素分析 [J]. 颈腰痛杂志 , 2020 , 41 ( 1 ): 90 - 92 .
孔超 , 鲁世保 , 孙祥耀 , 等 . 高龄腰椎管狭窄症患者手术治疗的安全性及有效性 [J]. 中国脊柱脊髓杂志 , 2018 , 28 ( 11 ): 1004 - 1010,1019 .
张俊锴 , 肖斌 , 许啸 . 独活寄生汤联合针刺治疗腰椎间盘突出症的临床效果 [J]. 世界中医药 , 2020 , 15 ( 7 ): 1067 - 1070 .
中华人民共和国卫生部 . 中药新药临床研究指导原则 [M]. 北京 : 人民卫生出版社 , 2002 : 346 - 349 .
中华中医药学会 . 中医骨科常见病诊疗指南 [M]. 北京 : 中国中医药出版社 , 2012 : 139 .
唐广军 . 独活寄生汤配合小切口腰椎管减压术治疗退行性腰椎管狭窄症的临床观察 [D]. 南京 : 南京中医药大学 , 2017 .
王远庆 , 吴耀持 . 超微针刀网点状松解法对腰椎间盘突出症患者 VAS评分和JOA腰椎疾患评分的影响 [J]. 陕西中医 , 2020 , 41 ( 4 ): 541 - 543 .
王光熙 , 闫景龙 . 腰椎管狭窄症疗效评分方法 [J]. 哈尔滨医科大学学报 , 2016 , 50 ( 3 ): 275 - 278 .
李鹏 . 改良后路经皮内镜下减压术治疗退行性腰椎管狭窄症对VAS、ODI评分的影响 [J]. 临床医学 , 2018 , 38 ( 2 ): 39 - 40 .
陈培 , 戴春宏 , 彭和兵 , 等 . 椎间孔镜治疗退行性腰椎管狭窄的临床疗效及其对腰椎功能评分的影响 [J]. 医学综述 , 2020 ( 7 ): 1402 - 1406 .
李勇 . 腰椎不稳的X线诊断与测量 [J]. 菏泽医学专科学校学报 , 2016 , 28 ( 2 ): 47 - 48,76 .
刘通 , 刘悦 , 邝伟川 , 等 . 刺骨调筋针法治疗腰椎术后失败综合征临床疗效 [J]. 中华中医药学刊 , 2018 , 36 ( 12 ): 2914 - 2917 .
唐广军 , 夏建龙 , 蔡平 , 等 . 独活寄生汤联合PCN治疗椎间盘源性腰痛的临床观察 [J]. 中国中医急症 , 2017 , 26 ( 5 ): 854 - 857 .
秦纪民 . 独活寄生汤结合后路减压植骨内固定术治疗退行性腰椎管狭窄症的临床效果 [J]. 临床医学研究与实践 , 2018 , 3 ( 25 ): 126 - 127 .
郭团茂 , 行艳丽 , 曹伟宁 , 等 . 椎间孔镜联合独活寄生汤治疗腰椎间盘突出症疗效观察 [J]. 现代中西医结合杂志 , 2020 , 29 ( 1 ): 1 - 4,38 .
邵银星 , 张建华 . 经椎间孔椎体间融合术联合独活寄生汤加减治疗单间隙腰椎管狭窄症20例 [J]. 安徽中医药大学学报 , 2020 , 39 ( 1 ): 21 - 24 .
李慧 , 马玉环 , 王圣杰 , 等 . 独活寄生汤抑制炎症介导软骨细胞基质降解的机制研究 [J]. 风湿病与关节炎 , 2019 , 8 ( 12 ): 5 - 8,26 .
王涛 , 李武强 . 独活寄生汤对肝肾亏虚型腰椎间盘突出症患者氧化应激及 β -内啡肽、IL-1 β 表达的影响 [J]. 吉林中医药 , 2020 , 40 ( 2 ): 212 - 215 .
刘伯龄 , 陈齐勇 , 付长龙 , 等 . 独活寄生汤调控对大鼠椎间盘软骨细胞Wnt/ β -catenin信号通路的影响 [J]. 风湿病与关节炎 , 2018 , 7 ( 1 ): 5 - 9,22 .
许丽梅 , 李慧 , 许云腾 , 等 . 基于NF- κ B信号通路探讨独活寄生汤抑制脂多糖诱导的软骨细胞炎症反应的作用机制 [J]. 中医正骨 , 2019 , 31 ( 7 ): 9 - 14,20 .
0
浏览量
18
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621